When discounted cards can assist reduce the load of large drug fees from the short-term, they don't address the systemic concerns driving up prescription rates during the U.S. Broader policy changes could tackle the foundation will cause of rising drug charges, such as not enough transparency in pricing as well as the role of intermediaries like PB